- $3.82bn
- $3.90bn
- $38.32bn
- 73
- 95
- 31
- 72
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 24,508 | 15,116 | 27,253 | 46,830 | 38,325 |
Cost of Revenue | |||||
Gross Profit | 3,084 | 840 | 3,427 | 7,781 | 5,654 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 23,859 | 16,555 | 26,576 | 42,743 | 35,379 |
Operating Profit | 649 | -1,439 | 677 | 4,087 | 2,946 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 480 | -1,331 | 328 | 3,558 | 2,886 |
Provision for Income Taxes | |||||
Net Income After Taxes | 375 | -1,333 | 316 | 2,973 | 2,162 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 319 | -1,392 | 231 | 2,877 | 2,141 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 319 | -1,393 | 231 | 2,877 | 2,141 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.5 | -13.3 | 1.23 | 24 | 14.6 |
Dividends per Share |